HomeFOLD • NASDAQ
add
Amicus Therapeutics, Inc.
Previous close
$10.33
Year range
$9.02 - $14.57
Market cap
3.06B USD
Avg Volume
2.15M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 110.40M | 27.97% |
Operating expense | 118.51M | 1.54% |
Net income | -48.42M | 8.53% |
Net profit margin | -43.86 | 28.52% |
Earnings per share | -0.02 | 88.89% |
EBITDA | -19.52M | 45.96% |
Effective tax rate | -11.10% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 239.60M | -10.30% |
Total assets | 721.79M | 3.04% |
Total liabilities | 591.10M | -1.15% |
Total equity | 130.69M | — |
Shares outstanding | 296.20M | — |
Price to book | 23.48 | — |
Return on assets | -7.23% | — |
Return on capital | -9.18% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -48.42M | 8.53% |
Cash from operations | -29.70M | -64.34% |
Cash from investing | 7.54M | -79.21% |
Cash from financing | -13.31M | -70.08% |
Net change in cash | -37.28M | -414.15% |
Free cash flow | -9.95M | -701.31% |
About
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, PA. The company went public in 2007 under the NASDAQ trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. Wikipedia
Founded
Feb 4, 2002
Website
Employees
517